Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

20 results
Display

Immunohistochemical Classification of Primary and Secondary Glioblastomas

Lee KS, Choe G, Nam KH, Seo AN, Yun S, Kim KJ, Cho HJ, Park SH

  • KMID: 2012155
  • Korean J Pathol.
  • 2013 Dec;47(6):541-548.
BACKGROUND: Glioblastomas may develop de novo (primary glioblastomas, P-GBLs) or through progression from lower-grade astrocytomas (secondary glioblastomas, S-GBLs). The aim of this study was to compare the immunohistochemical classification of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of Epidermal Growth Factor Receptor and the HER-2 Gene in Hormone Refractory Prostate Cancer

Cho KS, Kim DJ, Lee JS, Cho NH, Park K, Ham WS, Choi YD

  • KMID: 2312032
  • Korean J Urol.
  • 2008 Jan;49(1):24-30.
PURPOSE: Amplification and mutation of the epidermal growth factor receptor(EGFR) and HER-2 genes were analyzed in the tissues of hormone refractory prostate cancer(HRPC) patients. MATERIALS AND METHODS: Gene amplifications of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neuroepithelial Tumor Relevant Genes

Lee HC, Kim DW, Choi IJ, Lee JC, Son EI, Yim MB, Kim IH

  • KMID: 1673073
  • J Korean Neurosurg Soc.
  • 1994 Aug;23(8):924-931.
Cancer may be a disease of genes, arising from genetic damage of diverse sorts-recessive and dominant mutations, large rearrangement of DNA and gene translocation on chromosomes, all leading to distorisions...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gefitinib Treatment for Pulmonary Sarcomatoid Carcinoma Driven by an EGFR Mutation: Two Cases

Kim JY, Lim Y, Lee E, Kim MS, Lee DW, Kim TM, Lee SH

Sarcomatoid carcinoma of the lung is defined as a group of poorly differentiated non-small cell carcinomas that contain a component of sarcoma or a sarcoma-like element. Most sarcomatoid carcinomas are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer

Yoon SH, Choi YD, Oh IJ, Kim KS, Choi H, Chang J, Shin HJ, Park CK, Kim YC

PURPOSE: Direct sequencing (DS) is the standard method for detection of epidermal growth factor receptor (EGFR) gene mutation in non-small cell lung cancer (NSCLC); however, low detection sensitivity is a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mutational Analysis of the Epidermal Growth Factor Receptor Gene in Gastrointestinal Stromal Tumors

Yoo NJ, Lee JW, Soung YH, Jeon HM, Nam SW, Kim SY, Park WS, Lee JY, Lee SH

  • KMID: 2372342
  • J Korean Gastric Cancer Assoc.
  • 2004 Dec;4(4):268-271.
PUPOSE: Most gastrointestinal stromal tumors (GISTs) have gain-of-function mutations of the KIT or the platelet-derived growth factor receptor alpha (PDGFRA) genes, but approximately 10% of the GISTs are wild types...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Molecular Diagnosis in Lung Cancer

Lee KY

The advent of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) such as gefitinib and erlotinib has opened a new horizon for the therapeutic options for patients with advanced lung cancer....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cyto - molecular Biologic Characterization of c - myc , erb B and EGF - Receptor in Squamous Cell Carcinoma

Lee KS, Choi YY, Song JY, Choi IJ, Jang SI, Baek WK, Suh MH

  • KMID: 2230813
  • Korean J Dermatol.
  • 1994 Apr;32(2):223-233.
BACKGROUND: Oncogenes and EGF-Receptor(EGFR) may be involved n different stages of the multistep carcinogenesis process. A specific pattern of karyotypic abnormalities in solid tumors can be detected by cytogenetic methods. OBJECTIVE:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Increased expression of the epidermal growth factor receptor gene in psoriasis

Choi YY, Lee KS, Lee SS, Chang ES, Song JY

  • KMID: 2303592
  • Korean J Dermatol.
  • 1992 Aug;30(4):431-438.
Psoriasis is characterized by disregulation of keratinocyte growth with profound epidermal hyperplasia. Keratinocyte hyperplasia in psoriasis may be expained in part by overproduction of growth factor, and by altered metabolism...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Screening of Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer Using a PCR-Based Enzymatic Digestion Method

Jung YJ, Park SJ, Lee SB, Kim YT, Park JY, Park IK, Kang CH, Kim JH

PURPOSE: We applied a simplified method using polymerase chain reaction (PCR)-based enzymatic digestion for the detection of epidermal growth factor receptor (EGFR) mutation. MATERIALS AND METHODS: We selected 74 samples of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinicopathologic Analysis of Epidermal Growth Factor Receptor Status in Non-small Cell Lung Cancer: Protein Expression, Gene Amplification and Survival Analysis

Lee S, Choi J, Jang SJ

  • KMID: 1521612
  • Korean J Pathol.
  • 2007 Dec;41(6):387-392.
BACKGROUND: Abnormal over-expression or gene amplification of epidermal growth factor receptor (EGFR) is important in the prognosis of non-small cell lung cancer (NSCLC). We investigated the frequency of EGFR protein...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The EGFR Protein Expression and the Gene Copy Number Changes in Renal Cell Carcinomas

Lee S, An J, Kim A, Kim YS, Kim I, Genitourinary Pathology Study Group

BACKGROUND: The epidermal growth factor receptor (EGFR) is known to be involved in many tumor promoting activities. EGFR inhibition has been tried as a therapeutic modality in many human malignancies. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
EGFR Gene Amplification and Protein Expression in Invasive Ductal Carcinoma of the Breast

Hwangbo W, Lee JH, Ahn S, Kim S, Park KH, Kim CH, Kim I

  • KMID: 2277454
  • Korean J Pathol.
  • 2013 Apr;47(2):107-115.
BACKGROUND: The epidermal growth factor receptor (EGFR) is a surrogate marker for basal-like breast cancer. A recent study suggested that EGFR may be used as a target for breast cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intron 1 Polymorphism, Mutation and the Protein Expression of Epidermal Growth Factor Receptor in Relation to the Gefitinib Sensitivity of Korean Lung Cancer Patients

Kim MJ, Shin KC, Lee KH

BACKGROUND: Epidermal growth factor receptor (EGFR) intron 1 polymorphism in non-small cell lung cancer (NSCLC) has been found to have therapeutic implications for the patients treated with EGFR tyrosine kinase...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

Kim A, Jang MH, Lee SJ, Bae YK

PURPOSE: Epidermal growth factor receptor (EGFR) is considered a potential therapeutic target for anti-EGFR therapy in triple-negative breast cancer (TNBC). However, the frequency of EGFR gene mutation in TNBC is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Direct Sequencing, PNA Clamping-Real Time Polymerase Chain Reaction, and Pyrosequencing Methods for the Detection of EGFR Mutations in Non-small Cell Lung Carcinoma and the Correlation with Clinical Responses to EGFR Tyrosine Kinase Inhibitor Treatment

Lee HJ, Xu X, Kim H, Jin Y, Sun P, Kim JE, Chung JH

  • KMID: 1837571
  • Korean J Pathol.
  • 2013 Feb;47(1):52-60.
BACKGROUND: The aims of this study were to evaluate the abilities of direct sequencing (DS), peptide nucleic acid (PNA) clamping, and pyrosequencing methods to detect epidermal growth factor receptor (EGFR)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
In Situ Hybridization of EGFR mRNA in Normal, Dysplasic, Carcinoma In Situ and Malignant Cervical Tissues

Kim TE, Kim HK, Park JS, Kim JW, Kang JH, Lee AH, Kim JH, Namkoong S

  • KMID: 1675665
  • Korean J Gynecol Oncol Colposc.
  • 1995 Dec;6(4):235-243.
The specific receptor for epidermal growth factor(EGFR) was first purified from the A431 cell line which was derived from an epiderrnal carcinoma of the vulva. It is a 170,000 dalton...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma

Kim SY, Myung JK, Kim HR, Na II, Koh JS, Baek HJ, Kim CH

BACKGROUND: Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancers have emerged as key predictive biomarkers in EGFR tyrosine kinase inhibitor (TKI) treatment. However, a few patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative Analysis of Peptide Nucleic Acid (PNA)-Mediated Real-Time PCR Clamping and DNA Direct Sequencing for EGFR Mutation Detection

Kim HJ, Kim WS, Shin KC, Lee GH, Kim MJ, Lee JE, Song KS, Kim SY, Lee KY

  • KMID: 2319463
  • Tuberc Respir Dis.
  • 2011 Jan;70(1):21-27.
BACKGROUND: Although the gold standard method for research trials on epidermal growth factor receptor (EGFR) mutations has been direct sequencing, this approach has the limitations of low sensitivity and of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predicting the Treatment Response Using a Direct Sequencing Method for EGFR in Non-Squamous, Non-Small Cell Lung Cancer

Park JY, Jang SH, Kim HJ, Park YB, Kwon JH, Song HH, Lee KW, Kim JH, Kim JH, Park SH, Hwang YI, Kim DG, Jung KS

  • KMID: 2264117
  • Korean J Med.
  • 2011 Nov;81(5):611-622.
BACKGROUND/AIMS: Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancers (NSCLCs) have emerged as a key predictive biomarker for EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment and should be...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr